- Home
- Our company
- Social impact
- Global health equity
- Global health equity news & press releases
Global health equity news & press releases
Johnson & Johnson Innovation Launches Advancing the Safe Use of Healthcare Products QuickFire Challenge
Challenge awards up to $200,000 to novel solutions that advance safety by informing patients and consumers, simulating surgical procedures or ensuring proper storage and use of prescription, over-the-counter and cosmetic products
Johnson & Johnson Names Winners of First Africa Innovation Challenge
Competition Part of Company’s Eighty-Five Year Commitment to Supporting Entrepreneurs, Science Education Opportunities, and Health Systems Across the Continent
Spread my wings
A portrait of Nyumbani featuring a song performed by Grace Wairimu, a child of Nyumbani.
Johnson & Johnson Announces World Health Organization will Review Ebola Vaccine Regimen for Emergency Use Assessment and Listing (EUAL)
Preparations also underway to initiate first-in-human study for multivalent vaccine regimen to combat Ebola, Sudan and Marburg viruses
No more epidemics
Dr. Johan Van Hoof, Global Head of Janssen Vaccines, sat down for an on-camera interview with The Business Debate that has been posted on The Wall Street Journal. He spoke about Johnson & Johnson’s commitment to combat Ebola through Janssen’s vaccine development program, global partnerships and broader activities to promote pandemic preparedness.
U.S. FDA Approves Vermox™ Chewable (Mebendazole) For Treatment of Children and Adults With Roundworm and Whipworm Infections
New tablet formulation provides alternative treatment for millions of children around the world infected by intestinal worms
Johnson & Johnson Announces World Health Organization will Review Ebola Vaccine Regimen for Emergency Use Assessment and Listing (EUAL)
Preparations also underway to initiate first-in-human study for multivalent vaccine regimen to combat Ebola, Sudan and Marburg viruses
U.S. FDA Grants Priority Review to Janssen’s New Drug Application for Chewable Mebendazole Tablets Intended to Treat Soil-Transmitted Helminthiasis
Johnson & Johnson shows ongoing commitment to London Declaration on NTDs through advancement of new chewable tablet
